DMK

DMK Pharmaceuticals is a biopharmaceutical company focused on neuroscience, deeply affected by the devastating impact of opioid use disorder (addiction), and has created a library of small molecule neuropeptide analogs. Its portfolio aims to address the most pressing unmet needs in neurological disorders. The diseases targeted for treatment include chronic pain, Parkinson's disease, depression, bladder conditions, and more.